OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related...

11
8/7/19 1 OBESITY MANAGEMENT The Nuts & Bolts...and Springs & other Things. DISCLOSURES NONE OBJECTIVES 1. Discuss current definitions, diagnostics and prevalence of Obesity. 2. Review recommended treatment components of Obesity management. 3. Increase knowledge of clinical Obesity care through case study reviews. MY GOAL THROUGH THIS PRESENTATION IS TO SHARE HOPE WITH PROVIDERS ENCOUNTERING PATIENTS WITH OBESITY. HOPE is defined as a feeling of optimism or desire that something (good) will happen. Good things can always happen when we have the right information & preparation. Helping Obesity Providers Engage patients through education~ WHAT IS OBESITY? Obesity is a chronic, progressive, relapsing, multi-factorial, neurobehavioral disease, wherein an increase in body fat promotes adipose tissue dysfunction & abnormal fat mass physical forces, resulting in adverse metabolic, biomechanical & psychosocial health & consequences (OMA, 2019). Obesity is abnormal or excessive fat accumulation that presents a risk to health(WHO, 2018). Obesity is a serious chronic disease with extensive & well-defined pathologies, including illness & death (TOS, 2018). Obesity was recognized by the American Medical Association (AMA) in 2013, but we are still battling reimbursement. ABCD-Adiposity-Based Chronic Disease (AACE, 2017). Stress Obesity Genetics

Transcript of OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related...

Page 1: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

1

OBESITY MANAGEMENTThe Nuts & Bolts...and Springs & other Things.

DISCLOSURESNONE

OBJECTIVES

1. Discuss current definitions, diagnostics and prevalence of Obesity.2. Review recommended treatment components of Obesity management.

3. Increase knowledge of clinical Obesity care through case study reviews.

”MY GOAL THROUGH THIS PRESENTATION IS TO SHARE HOPE WITH PROVIDERS ENCOUNTERING PATIENTS WITH OBESITY.

HOPE is defined as a feeling of optim ism or desire that som ething (good) w ill happen. G ood things can always happen when we have the right inform ation & preparation.

Helping Obesity Providers Engage patients through education~

WHAT IS OBESITY?• Obesity is a chronic, progressive, relapsing, multi-factorial,

neurobehavioral disease, wherein an increase in body fat promotes adipose tissue dysfunction & abnormal fat mass physical forces, resulting in adverse metabolic, biomechanical & psychosocial health & consequences (OMA, 2019).

• Obesity is abnormal or excessive fat accumulation that presents a risk to health(WHO, 2018).

• Obesity is a serious chronic disease with extensive & well-defined pathologies, including illness & death (TOS, 2018).

• Obesity was recognized by the American Medical Association (AMA) in 2013, but we are still battling reimbursement.

• ABCD-Adiposity-Based Chronic Disease (AACE, 2017).

Stress

Obesity

Genetics

Page 2: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

2

WHAT OBESITY IS NOT…

• Obesity is not a result of anything a person has done “wrong.”• The related health consequences are not just “associated risk factors” or

“co-morbid conditions.”

• Obesity treatment is not as simple as eat less and move more.

WHO IS AFFECTED ?

Adults-650 million worldwide (2016)

-93 million U.S. adults (2015-16)-2 in 3 (2013-14)-40% of the population

Men

-over 73% or 3/4*2.8 million people die annually

Children-340 million worldwide (2016)

-13.7 million U.S. children (2015-16)-1 in 6 (2013-14)-20% of the population

Women

-over 66% or 2/3*$147 billion spent annually in the U.S.

PREVALENCE¶ OF SELF-REPORTED OBESITY AMONG U.S. ADULTS BY STATE AND TERRITORY, BRFSS, 2017

¶ P reva len ce estim ates re flect B R FS S m eth odo log ica l ch an ges started in 2 0 1 1 . Th ese estim ates sh ou ld n o t be com pared to p reva len ce estim ates be fore 2 0 1 1 .

* S am ple s ize < 5 0 o r th e re la tive stan dard erro r (d iv id in g th e stan dard erro r by th e p reva len ce) ≥ 3 0 % .

PREVALENCE OF SELF-REPORTED OBESITY AMONG NON-HISPANIC BLACK ADULTS, BY STATE AND TERRITORY, BRFSS,

2015-2017

* S am ple s ize < 5 0 o r th e re la tive stan dard erro r (d iv id in g th e stan dard erro r by th e p reva len ce) ≥ 3 0 % .

PREVALENCE OF SELF-REPORTED OBESITY AMONG HISPANIC ADULTS, BY STATE AND TERRITORY, BRFSS, 2015-2017

* S am ple s ize < 5 0 o r th e re la tive stan dard erro r (d iv id in g th e stan dard erro r by th e p reva len ce) ≥ 3 0 % .

PREVALENCE OF SELF-REPORTED OBESITY AMONG NON-HISPANIC WHITE ADULTS, BY STATE AND TERRITORY, BRFSS, 2015-2017

* S am ple s ize < 5 0 o r th e re la tive stan dard erro r (d iv id in g th e stan dard erro r by th e p reva len ce) ≥ 3 0 % .

Page 3: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

3

HOW DO WE DIAGNOSE OBESITY?BMI

Waist Circumference

Neck Circumference

Body Fat Composition

IT’S ABOUT SO MUCH MORE THAN BMI…

OBESITY CLASSIFICATION AND STAGINGEdmonton Obesity Staging System• Stage 0=no obesity related risk

factors• Stage1=preclinical risk factors (pre-

HTN or pre-DM), minor aches/pains

• Stage 2=presence of obesity related disease processes

• Stage 3=organ damage (MI, CHF, DM+)

• Stage 4=severe disabilities & limitations (WC, walker, scooter, bed bound)

“Normal” Weight 18.5-

24.9

Overweight

25.0-29.9

Class I Obesity

30.0-34.9

Class II Obesity

35.0-39.9

Class III Obesity

>=40

OTHER OBESITY RELATED MEASUREMENTS

Waist Circumference• Men >40 inches• Women >35 inches

Neck Circumference• >17 inches Men• >16 inches Women

WAIST TO HEIGHT RATIO

-waist goal=<1/2 height

CONSEQUENCES OF OBESITY

Psychosocial

Endocrine-DM , PCOS

G astrointestinal-Fatty Liver, G ERD

Oncology-Breast, Esophageal, Colon

CardiovascularHem atology-Anem ia, M yelom a

Pulm onary-Dyspnea, Sleep Apnea

Neurologic-CVA, Nerve Entrapm ent

Renal

M usculoskeletal-OA, M yalgia, G ait

Integum ent-Cellulitis, Venous Stasis Ulcers

BENEFITS OF WEIGHT REDUCTION

Endocrine Avoid DM 2

Im prove DM 2 control

Cardiovascular Im prove BP

Im prove cholesterol levels

RespiratoryReduce sym ptom s of Sleep Apnea

M anage COPD sym ptom s

HOW DO WE TREAT OBESITY?The first step is to identify it.

Page 4: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

4

THE SECOND STEP IS ASSESSMENTHistory & Physical, diagnostics and contributing factors

It’s about so much more than BMI…

THE 5 A’S OF OBESITY MANAGEMENTA-ask: “Is it okay if we talk about your weight?”

A-assess: Diagnostics/contributing factors

A-advise: Benefits of weight reduction/options

A-agree: Realistic goals

A-arrange: Resources/referrals; FOLLOW UP

ASSESSMENT• Medical history (diseases/conditions,

surgeries, medications, allergies); family history

• Psychosocial history (anxiety, depression, major life events, PTSD)

• Weight history (weight last year, most comfortable weight, highest/lowest, time frame, inciting factors, previous attempts)

• Nutrition history (when, what, how much, why, who prepares)

• Physical activity history (how much, how often, what type)

• Sleep (how much, quality, sleep symptoms)

• Labs (CBC, CMP, TSH, A1C, Insulin, lipids, vitamin D, B12, uric acid, UA, microalbumin)

• EKG• Depression/Anxiety Screening• Sleep Apnea Screening• Weight inducing medications• Advise (discuss benefits of weight

reduction, options)• Arrange for follow up

THE THIRD STEP IS BUILDING A TREATMENT PLANEvery patient is different; therefore every treatment plan varies. There are no cookie cutter approaches to managing obesity.

TREATMENT PLANNING INCLUDES…

• NUTRITION• PHYSICAL ACTIVITY• BEHAVIOR• MEDICATION• BARIATRICS

GOAL: 1. IMPROVE HEALTH2. IMPROVE QOL3. IMPROVE BODY WEIGHT AND COMPOSITION

TREATMENT PARAMETERS TO CONSIDER

• BMI >/= 30 or >/= 27 + comorbidityRequire high intensity lifestyle modificationsMay also require medications

• BMI >/= 40 or >/= 35 + comorbidityRequire high intensity lifestyle modificationsReferral to bariatric specialist

• Efficacy measured by % (4-5%)of total body weight loss over time (12-16 weeks; 3-4/6 months)

Page 5: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

5

NUTRITION CONSIDERATIONS

• When do they eat?• What do they eat?

• How much do they eat?• Do they snack? If so, when & on what?• Why do they eat?

• Where do they eat?• Who does the shopping/food preparation?

• How much time between meals?• Barriers (income, food availability, allergies, restrictions)

NUTRITION PLANNING1. Meal Plans• LOW CARB MEAL PLANS (50-150gm/day)• MEDITERRANEAN STYLE EATING• LOW-FAT MEAL PLANS (10-30% cal from fat)• DASH EATING PLAN• VEGETARIAN STYLE EATING• VERY LOW CALORIE (<800 CAL/DAY)• KETOGENIC MEAL PLANS2. Meal Replacements3. Intermittent Fasting4. Timing of Meals5. Food Sequencing

NUTRITION

• All calories are NOT created equal (protein vs carbs vs fats).• All fats are NOT created equal (saturated vs unsaturated).

• Nutrition is responsible for about 80%-90% of weight loss.• Consider the patients nutrition history (Timing of 1st meal of the day, time

between meals, who prepares meals, who shops, any dietary restrictions or other considerations).

• Calorie & carbohydrate restriction are key.

• An initial calorie reduction goal is about 500 calories per day (targeting carbs 1st).

• Food Journaling is also key to success.

NUTRITION 1ST STEPS1. Begin eating breakfast every day. Breakfast is best within 30 minutes to 1

hour of arising each day. Protein + Carbs2. Begin eating every 3-4 hours throughout the day. Load with Protein.3. Begin food journaling.4. Try to consume ½ your body weight in ounces of fluid (water) per day.5. Schedule follow up.

*People typically underestimate their calories by 1/3.

PHYSICAL ACTIVITY (PA)• Do they currently exercise?• Are they physically able to exercise?• What type of exercise do they currently

perform? How much? How often? Intensity?

• What do they like to do?• Referral for PT evaluation PRN• Referral to personal trainer• Other forms of PA (NEAT)• Exercise RX• NEW Guidelines• FITTE

PHYSICAL ACTIVITY

• PA is only responsible for about 10-20% of weight loss• PA is responsible for about 80-90% of weight maintenance

• New guidelines:1. Goal is “move more, sit less.”2. 10-minute increments are no longer suggested “starting point.”3. Mixture is key,(along with enjoyment factor)4. 150-300-minutes of moderate intensity/week5. 75-150-minutes of high intensity/week6. 2 + days of strength training

Adapted from Physical Activity Guidelines for Americans, 2nd edition. Available @ health.gov/PA Guidelines

Page 6: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

6

PHYSICAL ACTIVITY

Moderate Intensity Activities

• Brisk Walk (4 mph)• Heavy cleaning (mopping, window

washing, vacuuming)

• Bicycling (10-12 mph)• Lawn mowing

High Intensity Activities

• Hiking• Jogging (6 + mph)

• Shoveling• Bicycling (14-16 mph)• Basketball game

• Soccer game

STRENGTH TRAINING

• Canned goods• Bands

• Light weights• Pilates• Yoga

• Tai chi• Barriers

EXERCISE PRESCRIPTIONS

• F-frequency: number of days per week• I-intensity: light (casual walk), moderate (brisk walk), high (jogging/running)

• T-time: 5, 10, 20, 30, 45, 60 minutes or more• T-type: aerobic (walk, run, bike, swim, etc.); strength (push-ups, lunges,

weights, bands, balance)• E-enjoyment: The best exercise is one they enjoy.

WALKING IS A GREAT ACTIVITY< 5K steps per day = Sedentary

5K to 7.5K steps per day = low activity

7.5K to 10K steps per day = somewhat active

~10K steps per day = active

• The Average U.S. adult gets <5K steps per day• People overestimate their exercise by ~1/2

PHYSICAL ACTIVITY 1ST STEPS

1. Walk for 5-10 minutes every day.2. Get up from your work space, home space or school space every hour

and walk around.

3. Provide an Exercise Prescription.4. Encourage increased NEAT activities (good posture, standing vs sitting,

walk in place, fidgeting, cleaning, stair climbing & other ADLs) 5. Log your activity specifically (activity journal, pedometer, FitBit, or other

smart watch, MyFitnessPal)

6. Schedule follow up.

BEHAVIORReadiness to Change

Page 7: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

7

BEHAVIORAre their behaviors affecting their health? Are they aware?Are they ready to change their behavior(s)?Barriers to change?

Stages of Change:1) Pre-contemplation-unaware2) Contemplation-considering3) Preparation-planning

4) Action-doing it5) Relapse-return to old habits

BEHAVIOR CHANGE INVOLVES…

• Self monitoring (food & activity journaling)• Stress management (relaxation, meditation, Yoga, Tai Chi, etc.)

• Stimulus control (replacing “feel good foods” with “feel good activities”)• Social support (support group, workout buddy)• Motivational Interviewing

• Goal Setting

MOTIVATIONAL INTERVIEWINGO-open-ended questions

A-affirmations

R-reflection (listening)

S-summary

This Photo by Unknown Author is licensed under CC BY-NC-ND

SMART GOALSSpecific: What are some healthy eating or activity habits you can start doing?Measurable: How will you track these habits? How often will you do these things?Attainable: How confident are you about reaching this goal?

Relevant: Why are these things important to you?Timely: When will you start?

*What are you able to do today?*What are you willing to do today?

Adapted from AANP Let's Talk Weight & Your Well-being Toolbox

IN ORDER FOR BEHAVIOR CHANGE TO OCCUR…

• Patient must be involved in the plan• Shared partnership

• Referral to mental health may be necessary

*What are you able to change today?

*What are you willing to change today?

BEHAVIOR 1ST STEPS

1. Set First Goal (s)2. What are you able to do to get there?

3. What are you willing to do to get there?4. Track the Goals5. Catch them doing something right and acknowledge it.

6. Provide take home information on Nutrition, Physical Activity & Medication options.

7. Schedule follow up

Page 8: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

8

SUCCESSFUL WEIGHT MAINTAINERS…• Eat breakfast daily (78%)• Weigh at least 1 time per week (75%)• Watch less than 10 hours of TV per

week (62%)• Exercise about 1 hour per day (90%)• Burn about 2000 kcal/week in PA• Maintain restricted calories (1300-

1400/day)• Perform self-monitoring (weight/calorie

counting)• Eat more frequently throughout the

day (up to 5 times)

MEDICATIONSAdjunct therapy…

• Adjunct therapy to nutrition & physical activity.• If response to medication is superior (5%-10% weight loss in 12-16

weeks) continue meds indefinitely.• No clinical response in 12-16 weeks increase dose or change

med; DO NOT GIVE UP ON THERAPY!

• Monitoring of response/tolerance is key. FOLLOW UP!• Some experts recommend treating obesity first, so consider meds

early.• Therapy must be CONSISTENT. If there are breaks, start over.

• Obesity is a chronic disease. Chronic diseases require lifelong therapy.

MEDICATION CONSIDERATIONS

OBESOGENIC MEDICATIONS

CardiovascularBeta Blockers (“lols”)

Calcium Channel Blockers (“ines”)

DiabetesInsulin

Sulfonylureas (G lim epiride, G lyburide, G lipizide)

TZDs/”glitazones” (Actos/Avandia)

Anti-SeizureCarbam azepine/Tegretol

G abapentin/Neurontin

Valproate/Depakote

Pregabalin/Lyrica

OBESOGENIC MEDICATIONS

Hormones G lucocorticoids

Estrogens

MigraineElavil

Paroxetine

Propranolol (Beta Blockers)

PsychotropicsAntidepressants: Paxil, Celexa, Lexapro

M ood Stabilizers: Lithium , Depakote

Antipsychotics: Zyprexa/olanzapine, Risperdal/risperidone

WEIGHT NEUTRAL ALTERNATIVES

CardiovascularACEs

ARBs

Som e BBs (carvedilol)

DiabetesM etform in

G LP1-agonists (V ictoza, Bydureon, Trulicity, Ozem pic)

SG L-2 inhibitors (Jardiance, Invokana, Januvia)

Anti-SeizureLam ictal/lam otrigine

Topam ax/topiram ate

Zonegran/zonisam ide

Page 9: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

9

WEIGHT NEUTRAL ALTERNATIVES

HormonesTestosterone

MigraineTopiram ate

PsychotropicsAnti-depressants: Zoloft, Effexor, W ellbutrin, Trintellix

M ood Stabilizers: Lam ictal, Topiram ate

FDA APPROVED ANTI-OBESITY MEDICATIONS

• Liraglutide (Saxenda)-increases feelings of fullness (satiety); decreases appetite; results in reduced intake

• Naltrexone/Bupropion (Contrave)-regulates appetite; reduces cravings

• Phentermine-appetite suppression; reduced intake• Phentermine/Topiramate (Qsymia)-appetite suppression; reduced intake;

increased satiety• Lorcaserin (Belviq)-increases satiety; reduces intake

• Orlistat (Xenical/Alli)-reduces fat absorption

*Metformin…insulin resistance

• EKG abnormalities (infarcts, ischemia, bundle branch blocks, QTc prolongation, PVCs, etc.)

• Uncontrolled HTN (Phentermine, Qsymia, Contrave, & Belviq)

• Allergies to any of the components• Current anti-depressant therapy (Belviq & Contrave)• Current opioid therapy (Contrave)

MEDICATION CAUTIONS & CONTRAINDICATIONS WHAT WORKS IN MY PRACTICE

Visit one1) Identify 5) Agree

2) Ask 6) Arrange

3) Assess

4) Advise

Visit two1) Assess

2) Advise

3) Agree

4) Arrange

Visit three1) Assess

2) Advise

3) Agree

4) Arrange

VISIT ONE…• Identify- BMI, waist circumference, neck circumference, height/waist ratio• Ask- “Is it okay if we discuss your weight?” (as it relates to your health)• Assess- Interest in further discussion; labs/EKG • Advise- Weight related health risk factors; presence of weight related health

conditions; improvements in health with 5-10% reduction in weight; treatment options including nutrition (meal replacements), physical activity, & medications

• Agree- Some will want to know what they can do NOW. Agree on a few simple goals: 1) Start eating every 3 hours. 2) Photo journal all foods eaten. 3) Walk for 5 or 10 minutes per day.

• Arrange- Follow up in 1-2 weeks

VISIT TWO…• Assess- Review labs/EKG, food journal; exercise log; PHQ9 for depression

screening; GAD 7 for anxiety screening; Sleep apnea questionnaire• Advise- Recommendations for lab/EKG issues; additional testing; meal

replacements vs medications; eating frequency; food sequencing, calorie reduction/restriction, walking or other PA via Exercise Rx

• Agree- Initial goal setting to include nutrition and physical activity as well as a personal goal. Initial weight related goals planned in 5% & 10% increments in 3-month & 6-month intervals. Meal replacements &/or medications started

• Arrange- Referrals as necessary (cardiology, mental health, dietician, support group, PT, trainer, etc.); follow up in 1 week to 1 month based on treatment approach

• Tracking- 1st photos & measurements are taken

Page 10: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

10

VISIT THREE…

• Assess- Additional testing results (sleep study); referral results; tolerance to therapies; goal progress

• Advise- Food journal & Physical Activity journal recommendations; symptom/side effect management

• Agree- Goal changes/additions; continuation of treatments

• Arrange- Follow up in 1week or 1 month depending upon current therapy

FURTHER VISITS

• At least monthly for 3 months, some are every 2 weeks• Weekly if on VLCD/Ketogenic Meal Replacements until goal weight is

reached or plateau occurs. Coach visits with NP oversight.

• Labs and other necessary diagnostics are repeated at 3 months• Advanced Tracking is performed again at 3 months with repeat pictures &

measurements taken • Follow up is key to long term success

CASE STUDIESPutting the treatment plan into action HOPE

THANK YOU & PLEASE REMEMBER…HOPE IS A PIVOTAL COMPONENT IN CARING FOR

PATIENTS AFFECTED BY OBESITY~

QUESTIONS

JENNIFER KUCERA RN, CURN, APRN, FNP-CSweeny Medical Clinic

(979)[email protected]

Page 11: OBESITY MANAGEMENT DISCLOSURES · Edmonton Obesity Staging System • Stage 0=no obesity related risk factors • Stage1=preclinical risk factors (pre-HTN or pre-DM), minor aches/pains

8/7/19

11

ADDITIONAL RESOURCES

• American Association of Nurse Practitioners (AANP)-Introduction to Obesity Management in Primary Care

• AANP “Let’s Talk: Weight & Your Well-being” Toolbox/Flipchart

• American Association of Physician Assistants- Primary Care Obesity Management Certificate Program

• American College of Sports Medicine• Diabetes Prevention Program

• Exercise is Medicine• Obesity Medicine Association Certificate of Advanced Education

• The Obesity Society

REFERENCES1) Centers for Disease Control (2018). Adult Obesity Facts. Retrieved on 7/15/19.

https://www.cdc.gov/obesity/data/adult.html2) Centers for Disease Control-My Plate3) Harvard School of Public Health (2019). Obesity Prevention Source. Retrieved on

7/28/19. https://www.hsps.harvard.edu/obesity-prevention-source/moderate-and-vigorous-activity/

4) National Institutes for Health/National Institute of Diabetes & Digestive & Kidney Health (2017). Prevalence of Overweight & Obesity. Retrieved on 7/15/19. https://www.niddk.nih.gov/health-information/health-statistics/overweight-obesity#prevalence

5) World Health Organization(2017). Fact Sheet on Overweight & Obesity. Retrieved on 7/19/19. https://www.who.int/features/factfiles/obesity/en/

6) Sharma, A.M., Kushner, R. F. Edmonton Obesity Classification. International Journal of Obesity (2009)

7) Obesity Medicine Association (2019). Obesity Algorithm.

REFERENCES CONTINUED…

8) The Obesity Society (2018). Obesity as a Disease: The Obesity Society 2018 Position Statement. Obesity Vol (27) Num (1).

9) Physical Activity Guidelines for Americans (2019). Retrieved on 8/2/19. https://health.gov/paguidelines/second/edition/

10) Ziltzer, R. & Primack, C. (2019). Chasing Diets. Stop the Endless Search and Discover the solution.

11) American Association of Clinical Endocrinologists (2017). Adiposity-Based Chronic Disease as a New Diagnostic Term: The AACE/ACE Position Statement. Retrieved on 7/31/2019. https://www.aace.com/disease-state-resources/nutrition-and-obesity/position-and-consensusstatements/adiposity-based